Quick filters
24 Matches
1
- Osiris Therapeutics Announces First Quarter 2013 Financial Results Business Wire | Tuesday May 7, 2013 8:00AM
- Osiris Therapeutics to Present at the 12th Annual Needham Healthcare Conference Business Wire | Monday April 29, 2013 7:00AM
- Osiris Therapeutics Announces First Quarter 2013 Financial Results Conference Call Business Wire | Thursday April 25, 2013 5:00PM
- Osiris Therapeutics to Present at the Canaccord Genuity Musculoskeletal Conference Business Wire | Thursday March 14, 2013 7:00AM
- Osiris Therapeutics Reports Fourth Quarter and Full Year 2012 Financial Results Business Wire | Wednesday March 6, 2013 8:00AM
- Osiris Therapeutics Establishes Direct Sales Force for Grafix® Business Wire | Friday March 1, 2013 7:30AM
- Osiris Therapeutics Announces Fourth Quarter and Full Year 2012 Financial Results Conference Call Business Wire | Friday February 22, 2013 5:00PM
- Osiris Therapeutics Receives Title of European Orphan Drug Designation for Prochymal® Business Wire | Tuesday February 19, 2013 7:00AM
- Osiris Therapeutics Successfully Defends Key Stem Cell Patent Challenge Business Wire | Monday February 18, 2013 7:05PM
- Osiris Therapeutics to Present at the 24th Annual Piper Jaffray Healthcare Conference Business Wire | Tuesday November 20, 2012 4:00PM
- Osiris Therapeutics Reports Third Quarter 2012 Financial Results Business Wire | Monday November 5, 2012 8:00AM
- Osiris Therapeutics Announces Third Quarter 2012 Financial Results Conference Call Business Wire | Monday October 29, 2012 4:06PM
- Osiris Therapeutics Names Lode Debrabandere Chief Operating Officer Business Wire | Monday October 22, 2012 4:00PM
- Swissmedic Invokes Rapid Authorization Procedures for Prochymal Review Business Wire | Friday September 28, 2012 7:00AM
- Osiris Therapeutics Regains Worldwide Rights to Prochymal and Chondrogen Business Wire | Friday September 28, 2012 12:00AM
- Osiris Therapeutics Announces Change in its Board of Directors Business Wire | Thursday September 20, 2012 9:00AM
- Osiris Therapeutics to Present at 2012 UBS Global Life Sciences Conference Business Wire | Wednesday September 19, 2012 11:00AM
- Osiris Therapeutics Reports Second Quarter 2012 Financial Results Business Wire | Monday July 30, 2012 8:00AM
- Osiris Selected by BARDA to Submit Proposal for the Use of Grafix® in Mass Casualty Thermal Burn Injuries Business Wire | Friday July 13, 2012 9:00AM
- Osiris Therapeutics to Present at the Seventh Annual JMP Securities Healthcare Conference Business Wire | Thursday July 12, 2012 9:00AM
1
Live Discussion of OSIR on StockTwits